Yi Feng, Mou Tung-Chung, Dorsett Katherine N, Volkmann Robert A, Menniti Frank S, Sprang Stephen R, Hansen Kasper B
Department of Biomedical and Pharmaceutical Sciences, University of Montana, Missoula, MT 59812, USA.
Center for Biomolecular Structure and Dynamics, University of Montana, Missoula, MT 59812, USA; Division of Biological Sciences, University of Montana, Missoula, MT 59812, USA.
Neuron. 2016 Sep 21;91(6):1316-1329. doi: 10.1016/j.neuron.2016.08.014. Epub 2016 Sep 8.
NMDA receptors mediate excitatory synaptic transmission and regulate synaptic plasticity in the central nervous system, but their dysregulation is also implicated in numerous brain disorders. Here, we describe GluN2A-selective negative allosteric modulators (NAMs) that inhibit NMDA receptors by stabilizing the apo state of the GluN1 ligand-binding domain (LBD), which is incapable of triggering channel gating. We describe structural determinants of NAM binding in crystal structures of the GluN1/2A LBD heterodimer, and analyses of NAM-bound LBD structures corresponding to active and inhibited receptor states reveal a molecular switch in the modulatory binding site that mediate the allosteric inhibition. NAM binding causes displacement of a valine in GluN2A and the resulting steric effects can be mitigated by the transition from glycine bound to apo state of the GluN1 LBD. This work provides mechanistic insight to allosteric NMDA receptor inhibition, thereby facilitating the development of novel classes NMDA receptor modulators as therapeutic agents.
NMDA受体介导中枢神经系统中的兴奋性突触传递并调节突触可塑性,但其功能失调也与多种脑部疾病有关。在此,我们描述了GluN2A选择性负变构调节剂(NAMs),它们通过稳定GluN1配体结合域(LBD)的无配体状态来抑制NMDA受体,该无配体状态无法触发通道门控。我们在GluN1/2A LBD异二聚体的晶体结构中描述了NAM结合的结构决定因素,并且对与活性和抑制性受体状态相对应的NAM结合LBD结构的分析揭示了介导变构抑制的调节性结合位点中的分子开关。NAM结合导致GluN2A中的缬氨酸位移,并且从与GluN1 LBD的无配体状态结合的甘氨酸转变可以减轻由此产生的空间效应。这项工作为变构性NMDA受体抑制提供了机制性见解,从而促进了新型NMDA受体调节剂作为治疗剂的开发。